For the year ending 2025-12-31, IMDX made $4,055K in revenue. -$50,222K in net income. Net profit margin of -1238.52%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net revenue | 4,055 | |||
| Cost of revenues | 1,750 | |||
| Cost of revenues amortization of acquired intangibles | 7 | |||
| Gross profit | 2,298 | |||
| Research and development | 15,900 | |||
| Sales and marketing | 6,343 | |||
| General and administrative | 10,633 | |||
| Change in fair value of contingent consideration | 5,946 | |||
| Impairment losses | 14,600 | |||
| Total operating expenses | 53,422 | |||
| Loss from operations | -51,124 | |||
| Interest expense | -109 | |||
| Other income, net | 1,011 | |||
| Total other income, net | 902 | |||
| Loss before income taxes | -50,222 | |||
| Net loss | -50,222 | |||
| Basic EPS | -1.65 | |||
| Diluted EPS | -1.65 | |||
| Basic Average Shares | 30,476,000 | |||
| Diluted Average Shares | 30,476,000 | |||
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)